Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of DHEA and Testosterone Vaginal Rings in Postmenopausal Women
NCT03967964Phase 1Completed
- Sponsor
- Laboratorios Andromaco S.A.
- Start
- Nov 2015
- Primary completion
- Jul 2016
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dehydroepiandrosterone and Testosterone TEPI patch in growth hormone deficiency (GHD) (5 arms), sponsored by Laboratorios Andromaco S.A. Primary endpoints: Testosterone Area Under the Serum Concentration Time Curve (AUC0-72) at 72 hours, DHEA Area Under the Serum Concentration Time Curve (AUC0-72) at 72 hours and 6 more. Started Nov 2015; status: completed.
02
Drugs
dehydroepiandrosteroneTestosterone TEPI patch
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT03967964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03967964.